Discovery of potential bladder cancer biomarkers by comparative urine proteomics and analysis

Clinical Genitourinary Cancer

Volumn 11, Issue 1, 2013, Pages 56-62

  Lei, Ting ^a   Zhao, Xuhong ^a   Jin, Sheng ^a   Meng, Qian ^a   Zhou, Hui ^a   Zhang, Man ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Apolipoprotein A I; Biomarkers; Bladder cancer; Proteomics; Urine

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A1; BETA 2 MICROGLOBULIN; BINDING PROTEIN; BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; FATTY ACID BINDING PROTEIN; FIBRINOGEN; FIBRINOGEN ALPHA 2; GELSOLIN; ISOFORM 1 OF GELSOLIN; KERATIN TYPE II; KERATIN TYPE II CYSTOSKELETAL 1; KERATIN TYPE II CYTOSKELETAL 8; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 2; MEMBRANE PROTEIN; MYOGLOBIN; PREALBUMIN; PROSTAGLANDIN D2 SYNTHASE 21 KDA; PROSTAGLANDIN SYNTHASE; PROTEIN AMBP; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER PATIENT; CASE REPORT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN URINE LEVEL; PROTEOMICS; SENSITIVITY AND SPECIFICITY; TWO DIMENSIONAL GEL ELECTROPHORESIS; URINALYSIS; WESTERN BLOTTING;

APOLIPOPROTEIN A-I; CASE-CONTROL STUDIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84874525984     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2012.06.003     Document Type: Article

References (35)

1. B.L. Jacobs, C.T. Lee, J.E. Montie Bladder cancer in 2010: how far have we come? CA Cancer J Clin 60 2010 244 272
2. A. Jemal, R. Siegel, J. Xu Cancer Statistics, 2010 CA Cancer J Clin 60 2010 277 300
3. W.J. Sexton, L.R. Wiegand, J.J. Correa Bladder cancer: a review of non-muscle invasive disease Cancer Control 17 2010 256 268
4. B.W. Rhijn, H.G. Poel, T.H. Kwast Urine markers for bladder cancer surveillance: a systematic review Eur Urol 47 2005 736 748
5. A. Karl, S. Tritschler, D. Zaak Diagnostic procedure for bladder cancer Standards and current developments Urologe A 49 2010 1303 1311
6. T.M. Morgan, P.E. Clark Bladder cancer Curr Opin Oncol 22 2010 242 249
7. S.F. Shariat, Y. Lotan, A. Vickers Statistical consideration for clinical biomarker research in bladder cancer Urol Oncol 28 2010 389 400
8. S. Lintula, K. Hotakainen Developing biomarkers for improved diagnosis and treatment outcome monitoring of bladder cancer Expert Opin Biol Ther 10 2010 1169 1180
9. I. Proctor, K. Stoeber, G.H. Williams Biomarkers in bladder cancer Histopathology 57 2010 1 13
10. A. Saad, D.C. Hanbury, T.A. McNicholas A study comparing various noninvasive methods of detecting bladder cancer in urine BJU Int 89 2002 369 373
11. E.B. Avritscher, C.D. Cooksley, H.B. Grossman Clinical model of lifetime cost of treating bladder cancer and associated complications Urology 68 2006 549 553
12. T. Smrkolj, M. Mihelič, A. Sedlar Performance of nuclear matrix protein 22 urine marker and voided urine cytology in the detection of urinary bladder tumors Clin Chem Lab Med 49 2011 311 316
13. B.V. Offersen, M.M. Knap, M.R. Horsman Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival Acta Oncol 49 2010 1283 1287
14. S. Naito, V. Bilim, K. Yuuki Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer Clin Cancer Res 16 2010 5124 5132
15. S. Eguchi, Y. Yamamoto, S. Sakano The loss of 8p23.3 is a novel marker for predicting progression and recurrence of bladder tumors without muscle invasion Cancer Genet Cytogenet 200 2010 16 22
16. P. Ward-Smith, B. Miller, M. Caughron Applicability of the FISH test for bladder cancer Urol Nurs 30 2010 218 221
17. M. Ashburner, C.A. Ball, J.A. Blake Gene ontology: tool for the unification of biology The Gene Ontology Consortium Nat Genet 25 2000 25 29
18. S. Maere, K. Heymans, M. Kuiper BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks Bioinformatics 21 2005 3448 3449
19. K. Schwamborn, R.C. Krieg, J. Grosse Serum proteomic profiling in patients with bladder cancer Eur Urol 56 2009 989 996
20. J.M. Moreira, G. Ohlsson, P. Gromov Bladder cancer-associated protein, A potential prognostic biomarker in human bladder cancer Mol Cell Proteomics 9 2010 161 177
21. M. Tanaka, L. Müllauer, Y. Ogiso Gelsolin: a candidate for suppressor of human bladder cancer Cancer Res 55 1995 3228 3232
22. K.H. Tsui, P. Tang, C.Y. Lin Bikunin loss in urine as useful marker for bladder cancer J Urol 183 2009 339 344
23. F.L. Egerod, J.E. Svendsen, J. Hinley PPAR alpha and PPAR gamma coactivation rapidly induces Egr-1 in the nuclei of the dorsal and ventral urinary bladder and kidney pelvis urothelium of rats Toxicol Pathol 37 2009 947 958
24. Y.T. Chen, C.L. Chen, H.W. Chen Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology J Proteome Res 9 2010 5803 5815
25. M. Kuwamura, H. Yoshida, J. Yamate Urinary bladder rhabdomyosarcoma (sarcoma botryoides) in a young Newfoundland dog J Vet Med Sci 60 1998 619 621
26. T. Terada Sarcomatoid carcinoma of the urinary bladder: a case report with immunohistochemical and molecular genetic analysis Med Oncol 27 2010 547 553
27. G.R. Walton, P.A. McCue, S.D. Graham Beta-2-microglobulins as a differentiation marker in bladder cancer J Urol 136 1986 1197 1200
28. W. Engström Serum levels and urinary excretion of beta2-microglobulin in patients with urinary bladder carcinoma Eur Urol 14 1988 218 223
29. P.S. Chetty, L. Mayne, S. Lund-Katz Helical structure and stability in human apolipoprotein A-I by hydrogen exchange and mass spectrometry Proc Natl Acad Sci U S A 106 2009 19005 19010
30. M. Ehmann, K. Felix, D. Hartmann Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling Pancreas 34 2007 205 214
31. H. Gadomska, B. Grzechocińska, J. Janecki Serum lipids concentration in women with benign and malignant ovarian tumours Eur J Obstet Gynecol Reprod Biol 120 2005 87 90
32. H. Dieplinger, D.P. Ankerst, A. Burges Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer Cancer Epidemiol Biomarkers Prev 18 2009 1127 1133
33. J. Ai, Y. Tan, W. Ying Proteome analysis of hepatocellular carcinoma by laser capture microdissection Proteomics 6 2006 538 546
34. C.G. Gourin, W. Zhi, B.L. Adam Proteomic identification of serum biomarkers for head and neck cancer surveillance Laryngoscope 119 2009 1291 1302
35. H.H. Yang, X.F. Chen, W. Hu Lipoprotein(a) level and its association with tumor stage in male patients with primary lung cancer Clin Chem Lab Med 47 2009 452 457